[待更新] Intracellular Therapies, Inc. (ITI) is developing novel drugs for the treatment of depression, schizophrenia, Parkinson1s and Alzheimer1s disease and other Central Nervous System (CNS) disorders, based on proprietary targets identified and validated in vivo. Company develops compounds that have the potential to treat a wide range of diseases associated wit...
